Fox Chase Cancer Center molecular biologist named V Foundation Scholar

April 17, 2000

PHILADELPHIA (April 18, 2000)-- Dr. Dominique "Kiki" Broccoli of Cinnaminson, NJ, a molecular biologist at Fox Chase Cancer Center, was named a V Foundation Scholar in a special ceremony on Tuesday, April 18 at the Center. Nick Valvano, CEO of The V Foundation for Cancer Research (Cary, N.C.), awarded Broccoli a $100,000 check representing a two-year grant to pursue her research on cellular aging.

Named for North Carolina State University basketball coach James T. Valvano, who died of cancer in 1993, The V Foundation funds young investigators doing cutting-edge research. The V Foundation recently teamed with Papa John's International to raise funds and awareness for cancer research. From March 13th through the 26th, Papa John's restaurants donated $1 for every "Works" pizza sold in participating restaurants in Pennsylvania, New Jersey and Delaware. The donations contributed to Dominique Broccoli's V Foundation award.

Broccoli's research focuses on telomeres which are associated with cellular aging. Telomeres are specialized structures at the ends of chromosomes. In human cells, telomeric DNA is lost each time the cell divides due to the repression of a specialized enzyme, telomerase, which is responsible for the replication of telomeric DNA. Thus, telomeres become shorter as we age.

In most tumor cells, telomerase is active and telomere length is stabilized. The current hypothesis is that telomere length acts as a clock to limit the total number of divisions any cell is capable of achieving. This limitation on cell growth and renewal is believed to contribute to human aging.

Activation of telomerase and stabilization of telomeric DNA circumvents this restraint on cell growth and permits unlimited numbers of cell division, a process required for tumor formation. Thus, telomeres are critically important in both aging and the growth of tumors in humans. Although it is now clear that telomere length is a critical feature determining the number of divisions cells may attain, relatively little is known about how this process is regulated. The work funded by The V Foundation is focused on determining how telomeres limit cellular replication which may contribute to the development of new approaches to limit tumor growth.

Broccoli joined the medical science division of Fox Chase Cancer Center in June 1998. Previously she held a postdoctoral fellowship at Rockefeller University in New York City.

Broccoli received her bachelor's and master's degrees in biology from the University of Nevada-Reno and earned her Ph.D. in molecular biology and genetics in 1991 at Wayne State University in Detroit. Before beginning her fellowship in Rockefeller University's laboratory for cell biology and genetics, she completed a two-year postdoctoral fellowship in human genetics at Western General Hospital in Edinburgh, Scotland, in 1994.

Three other Fox Chase researchers, Dr. Hong Yan of Huntingdon Valley, Pa., Dr. Thomas R. Coleman of Jenkintown, Pa., and Dr. Peter D. Adams of Philadelphia, Pa., became V Foundation Scholars in 1997, 1998 and 1999 respectively.

Jim Valvano, the legendary head coach that led North Carolina State University to the 1983 NCAA basketball title, inspired millions with his valiant ten-month battle against a virulent form of bone cancer that finally claimed his life. The V Foundation was founded by Valvano just prior to his death in 1993. Jimmy V made headlines before he passed away when he proclaimed war against cancer with his famous statement, "DON'T GIVE UP...DON'T EVER GIVE UP!" Since its inception, The V Foundation has awarded 62 research and awareness grants and has raised more than $12 million. For more information about The V Foundation, please call 1-800-4-JIMMY V or visit
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at:

Fox Chase Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to